Cbdmd announces financing of $1,250,000

Charlotte, north carolina--(newsfile corp. - february 2, 2024) - cbdmd, inc. (nyse american: ycbd) (nyse american: ycbd-pa) (the "company"), a premier provider of high-quality cbd products and functional mushroom supplements under atrx labs today announced that it has entered into a securities purchase agreement (the "spa") with five institutional investors (the "investors") whereby the investors advanced the company an aggregate of $1,250,000 gross proceeds and the company issued each investor a senior secured original issue discount convertible promissory note (collectively, the "notes") in the aggregate principal amount of $1,541,666. the company intends to use the proceeds from the issuance of the notes for working capital general corporate purposes.
YCBD Ratings Summary
YCBD Quant Ranking